Antifection

Thiomarinol A, a potent antibiotic, primarily targets bacterial isoleucyl-tRNA synthetase (IleRS), particularly in methicillin-resistant Staphylococcus aureus (MRSA). This compound, a hybrid of dithiolopyrrolone and marinolic acid, demonstrates significant antimicrobial activity through a dose-dependent inhibition, with a Kiapp value of 19 nM. Thiomarinol A is valuable for research applications focused on antibiotic development and the study of resistant bacterial strains.

Platencin is a natural broad-spectrum antibiotic derived from Streptomyces platensis. It primarily targets β-ketoacyl-ACP synthases II and III (FabF and FabH), inhibiting their activity with IC50 values of 1.95 and 3.91 μg/ml, respectively. This compound exhibits potent antibacterial activity against Gram-positive bacteria and is of significant interest for research in antibiotic development and resistance.

PD 116779 is an antibiotic that exhibits significant anticancer activity. It demonstrates moderate cytotoxic effects against L1210 lymphocytic leukemia and HCT-8 human colon adenocarcinoma cell lines, with respective IC50 values of 3.55 x 10^-7 M and 4.08 x 10^-7 M. This compound is utilized in research applications focusing on the mechanisms of antibiotic resistance and the exploration of novel cancer therapeutics.

Aurein 3.1 is an antibiotic antimicrobial peptide that exhibits notable activity against Gram-positive bacteria. It demonstrates a minimum inhibitory concentration (MIC) of 80 μM against Micrococcus luteus and 50 μM against Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mutans, and Bacillus subtilis. Aurein 3.1 is valuable for research applications focused on combating bacterial infections and studying antimicrobial mechanisms.

Napyradiomycin A1 is an enantioselective compound belonging to the napyradiomycin family, characterized by its halogenated structure. This compound exhibits significant anti-tumor and antibacterial activities, making it a valuable tool in cancer research and microbiology. Its efficacy against various tumor cell lines, along with activity against select bacterial strains, positions Napyradiomycin A1 as a promising candidate for further investigation in therapeutic applications.

FR 901379 is an echinocandin-type lipopeptide antibiotic that targets fungal cell wall synthesis. Derived from a mutant strain of Coleophoma empetri, this compound exhibits potent antifungal activity against various pathogenic fungi. It is widely utilized in research to study fungal infections and evaluate the effectiveness of antifungal therapies.

Chloramphenicol succinate is a prodrug of Chloramphenicol, functioning primarily as an antibiotic. It acts as a competitive substrate and inhibitor of succinate dehydrogenase (SDH), which may contribute to its associated haemotoxicity. This compound is widely utilized in pharmacological research to investigate its antimicrobial properties and to study the mechanisms of SDH inhibition in various biological systems.

Espinomycin A2 is a sixteen-membered macrolide antibiotic that primarily targets bacterial ribosomes. This compound exhibits potent activity against Gram-positive bacteria, making it a valuable tool for studying bacterial inhibition and resistance mechanisms. Its efficacy in disrupting protein synthesis positions Espinomycin A2 as a relevant candidate in antibiotic research and development.

Kigamicin C is an anti-tumor antibiotic that selectively induces cell death in pancreatic cancer PANC-1 cells under nutrient-limiting conditions. This compound demonstrates notable antimicrobial activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Kigamicin C is a valuable reagent for research applications focused on cancer cell metabolism and antibiotic resistance mechanisms.

Dihydronovobiocin is a bacterial inhibitor that targets ATPase activity by binding to the GyrB subunit of DNA gyrase. This compound is useful for investigating the interactions between coumarin antibiotics, such as Novobiocin, Chlorobiocin, and Coumermycin, and their effects on DNA gyrase function. Dihydronovobiocin also has potential applications in the study of bacterial infections, facilitating research into the mechanisms of antibiotic action and resistance.

Sulfaethoxypyridazine is a sulfonamide antibacterial agent that primarily targets bacterial dihydropteroate synthase, inhibiting folate synthesis. This compound exhibits significant antibacterial activity, making it effective for use in veterinary medicine as an additive in feedstuffs. Its application is centered on the prevention and treatment of bacterial infections in livestock, enhancing animal health and productivity.

Penicillin G is a potent penicillin antibiotic targeting bacterial cell wall synthesis. It exhibits strong antibacterial activity against a wide range of Gram-positive bacteria and Gram-negative cocci. This compound is commonly used in research to study bacterial infections and the mechanisms of antibiotic resistance.

Sulbenicillin is an antibiotic with a primary action against bacterial cell wall synthesis. It has demonstrated differential activity against various strains of Pseudomonas aeruginosa, particularly in models of infection in mice. Notably, its efficacy against gentamicin-resistant strains is influenced by the specific resistance profiles of those strains. This compound is valuable in researching antibiotic resistance mechanisms and developing new therapeutic strategies.

IT-143B is an antibiotic that exhibits potent antibacterial activity against Micrococcus luteus, demonstrating a minimum inhibitory concentration (MIC) of 6.25 μg/mL. Additionally, IT-143B effectively inhibits the growth of KB cancer cells, with an IC50 value of 1.1 ng/mL. This compound is valuable for research applications in microbiology and cancer studies, providing insights into antibacterial mechanisms and potential therapeutic strategies.

6"-Deamino-6"-hydroxyparomomycin I is an aminoglycoside antibiotic targeting bacterial protein synthesis. It exhibits potent activity against both Gram-positive and Gram-negative bacteria, making it a valuable compound for studying bacterial resistance and antibiotic efficacy. Additionally, it serves as a key intermediate in the biosynthetic pathway of paromomycin, facilitating research in antibiotic production and modification.

m-Chloramphenicol is an impurity of the antibiotic Chloramphenicol, known for its broad-spectrum antimicrobial activity. It functions as a potent inhibitor of bacterial protein biosynthesis by targeting the 50S ribosomal subunit, disrupting polypeptide synthesis. This compound is valuable in research settings focused on antibiotic resistance mechanisms and bacterial protein synthesis studies.

Albofungin is an antibiotic isolated from the culture filtrate of Actinomyces tumemacerans strain INMI.P-42. It demonstrates potent antimicrobial activity against a diverse range of gram-positive bacteria and fungi. Additionally, Albofungin exhibits cytotoxic effects on HeLa cell cultures and shows significant antitumor activity in models such as the EHRLICH ascites tumor in mice, making it a valuable reagent for antibacterial and antineoplastic research applications.

Pirlimycin hydrochloride is a lincosamide antibiotic that exerts its antimicrobial effects by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit. It demonstrates significant activity against Gram-positive bacteria, making it a valuable reagent for research focused on bacterial infections and antibiotic resistance mechanisms. Its role in the study of protein synthesis inhibition provides insights into bacterial growth and susceptibility profiles.

Aurantimycin A is a depsipeptide antibiotic that targets Gram-positive bacteria, demonstrating potent antimicrobial activity. As a substrate of the LieAB transporter, it facilitates the study of bacterial resistance mechanisms and transporter functions. This compound is valuable for research in antibiotic development and microbial pathogenesis.

Angiolam A is an antibiotic derived from Angiococcus disciformis, primarily targeting bacterial cell wall synthesis. It demonstrates significant antibacterial activity against Gram-positive bacteria, making it a valuable tool in research focused on combating bacterial infections and studying antibiotic resistance mechanisms. Its distinctive mode of action contributes to the exploration of novel therapeutic strategies in microbiology.

Fluopsin C is a copper-containing antibiotic that exhibits potent antitumor activity. It also demonstrates significant antibacterial effects against both Gram-positive and Gram-negative bacteria. This compound is primarily utilized in research applications focused on cancer therapy and the study of bacterial infections, providing valuable insights into antibiotic resistance and therapeutic strategies.

Altromycin C is a pluramycin-like antibiotic that exhibits significant antibacterial activity. Structurally distinct from other pluramycin-type antibiotics, Altromycin C offers unique properties that warrant further investigation. Its potent bioactivity makes it a valuable reagent for studying antibiotic mechanisms and developing treatments against bacterial infections.

2',3'-Dideoxy-5-iodocytidine is an antibiotic that targets bacterial RNA synthesis. Exhibiting significant activity against Mycobacterium species, this compound is also utilized in gene sequencing applications. Its unique structure facilitates the examination of nucleic acid interactions and the development of antimicrobial strategies.

DZ-2640 is an orally active carbapenem antibiotic that functions as a prodrug of DU-6681. DU-6681 demonstrates potent antibacterial activity against a wide range of gram-positive and gram-negative bacteria. This compound is designed for research applications focused on combating bacterial resistance and understanding the mechanisms of antibiotic action.

Fandofloxacin hydrochloride is an orally active quinolone antibiotic targeting bacterial DNA gyrase, which inhibits bacterial DNA replication. This compound exhibits potent antibacterial activity against a range of gram-positive and gram-negative bacteria. Fandofloxacin hydrochloride is suitable for research related to bacterial infections and the assessment of its embryotoxic and teratogenic effects.

S 863390 is an antibiotic compound that inhibits the intestinal uptake system, thereby reducing the absorption of β-lactam antibiotics and small peptides. This interaction not only affects the uptake of these substances but also allows for S 863390 itself to be transported. It is valuable for research involving drug absorption and interaction studies, particularly in the context of enhancing antibiotic efficacy and understanding intestinal transport mechanisms.

Iturin A-2 is a cyclic lipopeptide antibiotic derived from Bacillus subtilis, demonstrating potent inhibitory activity against the plant pathogenic fungus Penicillium expansum with a minimal inhibitory concentration (MIC) of 8 µg/disk. This compound exhibits cytotoxic effects on various cancer cell lines, including MCF-7, BT474, and HeLa, with IC50 values of 66.81, 95.04, and 77.5 µg/mL, respectively. Additionally, Iturin A-2 effectively reduces lesion areas in southern corn leaf blight caused by Bipolaris maydis in greenhouse studies and decreases disease incidence in field studies at higher concentrations. At 12.5 µg/mL, Iturin A-2 inhibits cell division in isolated fertilized starfish eggs without affecting nuclear division.

SCH 34343 sodium is a potent β-lactam antibiotic that exhibits bactericidal activity against a broad spectrum of bacterial pathogens, including Streptococcus pneumoniae, viridans streptococci, and groups A, B, C, and G streptococci, as well as Streptococcus bovis. This compound is valuable for research applications in microbiology and infectious diseases, enabling studies on antibiotic resistance mechanisms and the efficacy of β-lactam antibiotics against clinically relevant strains.

Quinacillin is a β-lactam antibiotic that targets bacterial cell wall synthesis through irreversible covalent binding to penicillin-binding proteins. It is susceptible to hydrolysis by penicillinase, a mechanism that can diminish its efficacy against resistant strains. Quinacillin is primarily utilized in research applications aimed at understanding antibiotic resistance and the enzymatic mechanisms of β-lactamase activity. Its role in probing bacterial infections makes it a valuable reagent in microbiological studies.

Demethyl bleomycin A2 is a congener of the antibiotic Bleomycin, exhibiting strong DNA cleavage activity. It is noted for its insensitivity to 5-Methylcytidine, making it a valuable tool for research in nucleic acid interactions and cellular response mechanisms. This compound is suited for studies in cancer therapeutics and molecular biology, aiding in the exploration of DNA-targeting strategies.

Pikromycin is a macrolide antibiotic that targets bacterial protein synthesis by inhibiting RNA-dependent protein synthesis. It demonstrates significant antibacterial activity against a range of Gram-positive and Gram-negative organisms, including Escherichia coli, Staphylococcus aureus, and Bacillus subtilis. This compound is valuable for research applications in microbiology and antibiotic resistance studies.

Cefetamet hydrochloride is a cephalosporin antibiotic that exerts its antimicrobial effects by binding to bacterial penicillin-binding proteins (PBPs), with an IC50 of 2.5 μg/mL for PBP3 in Escherichia coli W3110. This compound demonstrates potent activity against a range of Gram-negative bacteria, such as Enterobacteriaceae, Neisseria species, and Haemophilus influenzae, as well as Gram-positive bacteria, including Streptococcus. Additionally, Cefetamet hydrochloride is effective in lysing Treponema pallidum. It is utilized in research focused on respiratory tract, urinary tract, ear, nose, and throat infections, as well as syphilis.

K-41 is an orally active antibiotic derived from Streptomyces hygroscopicus. This compound exhibits significant antibacterial and antiplasmodial activities, making it a valuable tool in research focused on infectious diseases. K-41 can be utilized in studies investigating potential treatments for malaria and bacterial infections, contributing to the development of new therapeutic strategies.

Deltamycin A1 is a macrolide antibiotic that exerts antibacterial activity through inhibition of bacterial protein synthesis. This compound's unique structural attributes, distinct from other macrolides, enhance its utility in microbiological research. Deltamycin A1 is valuable for studies investigating antibiotic resistance mechanisms and developing new therapeutic strategies against bacterial infections.

DRF-8417 is an oxazolidinone antibiotic that targets bacterial protein synthesis. It demonstrates significant antibacterial activity against Gram-positive and certain fastidious Gram-negative bacteria, with minimal inhibitory concentration (MIC50) and (MIC90) values ranging from 0.06 to 1 mg/L. This compound is suitable for research applications focused on combating Gram-positive infections and studying antibiotic resistance mechanisms.

Pezulepistat is a macrocyclic antibiotic that exhibits broad-spectrum activity against a variety of microbial pathogens. Its primary mechanism involves inhibiting bacterial protein synthesis, making it particularly effective against gram-negative bacterial infections. This compound is valuable for research applications focused on understanding antibiotic resistance and developing new therapeutic strategies for treating challenging infections.

Telomycin is a calcium-dependent antibiotic produced by Streptomyces species, with a primary mechanism of action that disrupts the growth of gram-positive bacteria. It demonstrates potent activity against multidrug-resistant (MDR) pathogens, making it a valuable tool for research in combating antibiotic resistance. Telomycin's unique properties position it as a critical compound for studies focused on bacterial infections and antibiotic development.

Albocycline is a macrolide antibiotic that primarily targets bacterial protein synthesis. It demonstrates potent antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA), as well as Vancomycin-intermediate (VISA) and Vancomycin-resistant Staphylococcus aureus (VRSA) strains, with minimum inhibitory concentrations (MICs) ranging from 0.5 to 1.0 μg/mL. Albocycline shows a favorable toxicity profile, exhibiting no harmful effects on human cells at concentrations of ≤64 μg/mL, making it a valuable candidate for research in antibiotic resistance studies.

Aurein 3.3 is an antimicrobial peptide with potent antibiotic properties. It exhibits a dual mechanism of action, targeting bacterial membranes and disrupting cellular integrity. Additionally, Aurein 3.3 demonstrates anticancer activity, making it a valuable resource for research into antimicrobial therapeutics and cancer biology. Its unique properties allow for diverse applications in the study of microbial resistance and cancer treatment strategies.

Enduracidin B is a polypeptide antibiotic derived from Streptomyces spp., primarily functioning by inhibiting bacterial cell wall synthesis. It exhibits potent antibacterial activity against a range of gram-positive bacteria. This compound serves as a valuable tool in antibiotic research and the study of mechanisms of resistance in pathogenic microorganisms.

Ascamycin is a 5'-O-sulfonamide ribonucleoside antibiotic derived from Streptomyces sp. JCM9888, targeting bacterial ribonucleoside metabolism. It exhibits potent selective antibacterial activity against Xanthomonas species, demonstrating minimum inhibitory concentration (MIC) values of 0.4 μg/mL for Xanthomonas citri, 12.5 μg/mL for Xanthomonas oryzae, and 12.5 μg/mL for Mycobacterium phlei. This compound serves as a valuable tool for research applications focused on bacterial infections and antibiotic resistance mechanisms.

(E)-Aztreonam is a monocyclic beta-lactam antibiotic that specifically targets bacterial cell wall synthesis. It exhibits significant antimicrobial activity against gram-negative pathogens, making it a valuable compound for the study of infections caused by these organisms. This reagent is ideal for research applications focused on antibiotic resistance, mechanism of action studies, and the development of new antimicrobial therapies.

PD 116152 is a phenazine antibiotic that exhibits both antimicrobial and antitumor properties. It demonstrates significant cytotoxic activity against L1210 lymphocytic leukemia and human colon adenocarcinoma (HCT-8) cells, with IC50 values of 5.2 x 10-7 M and 7.1 x 10-7 M, respectively. This compound offers potential for research applications in the study of P388 lymphocytic leukemia.

Teicoplanin sodium is a glycopeptide antibiotic primarily targeting Gram-positive bacteria. It is indicated for the treatment of serious infections caused by organisms such as Methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus faecalis. Additionally, Teicoplanin sodium exhibits antiviral activity against HIV-1, SARS-CoV-1, and SARS-CoV-2, making it a versatile agent in research applications focused on antimicrobial and antiviral efficacy.

(4-Aminobenzyl)phosphonic acid is a bioactive compound that acts as a bacterial inhibitor. It exhibits notable antibacterial and potential anticancer activities, making it useful in various research applications, particularly in the synthesis of new compounds aimed at inhibiting bacterial growth. Its unique structural properties enable effective interaction with biological targets, facilitating the exploration of novel therapeutic strategies.

Spectinomycin is an antibiotic that primarily targets bacterial ribosomes to inhibit protein synthesis. It exhibits broad-spectrum activity against various gram-positive and gram-negative organisms. Additionally, spectinomycin functions as a noncompetitive inhibitor of td intron RNA, making it a useful tool in studies of bacterial physiology and genetic regulation. Its applications extend to microbiological research and the exploration of antibiotic resistance mechanisms.

Bacillosporin C is an oxaphenalenone dimer that acts as a potent antibiotic. Isolated from the bacterium T. bacillosporus and derived from the lactone bacillosporin D found in the mangrove endophytic fungus SBE-14, Bacillosporin C demonstrates significant antibacterial properties. Additionally, it has been shown to inhibit acetylcholinesterase, making it a valuable tool for research in microbial resistance and neuropharmacology.

Corynecin III is an antibiotic derived from Corynebacterium that functions similarly to Chloramphenicol. It exhibits broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria, demonstrating minimum inhibitory concentrations (MIC) ranging from 2.6 to 83 μg/mL. This compound is valuable in research applications focused on antibiotic resistance and the development of new therapeutic agents.

Lavendomycin is a peptide antibiotic derived from Streptomyces that primarily targets Gram-positive bacteria. It exerts its antibacterial activity by disrupting bacterial protein synthesis, making it a valuable tool for research on antibiotic resistance and bacterial infections. Lavendomycin's efficacy against a range of Gram-positive pathogens highlights its potential applications in microbiological studies and therapeutic development.

Mandelonitrile benzoate is an antibiotic compound primarily derived from the defensive secretions of millipedes. This reagent exhibits notable biological activity against various pathogens, suggesting potential application in antimicrobial research. In addition to its antibiotic properties, mandelonitrile benzoate plays a role in the cyanidation process, releasing hydrocyanic acid and benzaldehyde. Its unique chemical profile contributes to the understanding of chemical defenses in millipedes, serving as a valuable tool in studying antipredator mechanisms and the chemotaxonomy of these organisms.